Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Statins and the brain: More than lipid lowering agents?
Anna Fracassi
, Martina Marangoni
, Pamela Rosso
, Valentina Pallottini
, Marco Fioramonti
, Silvia Siteni
, Marco Segatto
Research output
:
Contribution to journal
›
Review article
›
peer-review
102
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Statins and the brain: More than lipid lowering agents?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Statins
100%
Lipid-lowering Agents
100%
Central Nervous System
28%
Mevalonate Pathway
28%
Functional Outcome
14%
Neurodegeneration
14%
Biological Activity
14%
Pharmacokinetic Properties
14%
Rate-limiting Enzyme
14%
Plethora
14%
Brain Diseases
14%
Neuropathology
14%
Clinical Application
14%
Neurological Diseases
14%
Cholesterol
14%
Neuroprotective Effect
14%
Brain Tumor
14%
Dyslipidemia
14%
Pleiotropic Effects
14%
Statin Therapy
14%
3-hydroxy-3-methylglutaryl-CoA Reductase
14%
Up-To-date Information
14%
PubMed Database
14%
Brain Pathology
14%
Hmgr
14%
Brain Processes
14%
Statin Treatment
14%
Pharmacodynamic Properties
14%
Add-on Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Antilipemic Agent
100%
Statin (Protein)
50%
Mevalonic Acid
33%
Brain Disease
16%
Biological Activity
16%
Pharmacodynamics
16%
Nerve Degeneration
16%
Neuroprotective Agent
16%
Dyslipidemia
16%
Neurologic Disease
16%
Enzymes
16%
Oxidoreductase
16%
HMG-CoA
16%
Cerebrovascular Accident
16%
Pharmacokinetics
16%
Intracranial Tumor
16%
Cholesterol
16%
Neuroscience
Statin
100%
Hypolipidemic Agent
100%
Central Nervous System
22%
Neurodegeneration
11%
Neuroprotective Agent
11%
Nervous System Disorder
11%
Enzymes
11%
Dyslipidemia
11%
3 Hydroxy 3 Methylglutaryl Coenzyme A
11%
Cerebrovascular Accident
11%
Pharmacokinetics
11%
Brain Disease
11%
Intracranial Tumor
11%
Cholesterol
11%